(Q38109267)

29 August 2017

title

Papillomavirus transcripts and posttranscriptional regulation (English)

1 reference

29 August 2017

Stefan Schwartz

1

1 reference

29 August 2017

language of work or name

English

0 references

publication date

23 May 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

445

1 reference

29 August 2017

issue

1-2

1 reference

29 August 2017

page(s)

187-196

1 reference

Intron definition and a branch site adenosine at nt 385 control RNA splicing of HPV16 E6*I and E7 expression

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

The human immunodeficiency virus type 1 Rev protein and the Rev-responsive element counteract the effect of an inhibitory 5' splice site in a 3' untranslated region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

AU-rich elements and associated factors: are there unifying principles?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Viable adenovirus vaccine prototypes: high-level production of a papillomavirus capsid antigen from the major late transcriptional unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Inhibitory activity of the human papillomavirus type 1 AU-rich element correlates inversely with the levels of the elav-like HuR protein in the cell cytoplasm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

The alternative splicing factor hnRNP A1 is up-regulated during virus-infected epithelial cell differentiation and binds the human papillomavirus type 16 late regulatory element.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

The natural history of human papillomavirus infections of the mucosal epithelia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Uniformity of the splicing pattern of the E6/E7 transcripts in human papillomavirus type 16-transformed human fibroblasts, human cervical premalignant lesions and carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

The RNA stability regulator HuR regulates L1 protein expression in vivo in differentiating cervical epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Activity of the human papillomavirus type 16 late negative regulatory element is partly due to four weak consensus 5' splice sites that bind a U1 snRNP-like complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

The human papillomavirus type 31 late 3' untranslated region contains a complex bipartite negative regulatory element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

The papillomavirus life cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Increased expression of cellular RNA-binding proteins in HPV-induced neoplasia and cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Sequences homologous to 5' splice sites are required for the inhibitory activity of papillomavirus late 3' untranslated regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

The early noncoding region of human papillomavirus type 16 is regulated by cytoplasmic polyadenylation factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

The regulatory element in the 3'-untranslated region of human papillomavirus 16 inhibits expression by binding CUG-binding protein 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Papillomavirus 3' UTR regulatory elements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

tRNASer(CGA) differentially regulates expression of wild-type and codon-modified papillomavirus L1 genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

U1 snRNP inhibits pre-mRNA polyadenylation through a direct interaction between U1 70K and poly(A) polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Functional diversity of the hnRNPs: past, present and perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Control of the papillomavirus early-to-late switch by differentially expressed SRp20

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Regulation of bovine papillomavirus type 1 gene expression by RNA processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

HPV-16 E2 contributes to induction of HPV-16 late gene expression by inhibiting early polyadenylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Analysis of human papillomavirus type 16 E5 oncogene expression in vitro and from bicistronic messenger RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Human Fip1 is a subunit of CPSF that binds to U-rich RNA elements and stimulates poly(A) polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

The human papillomavirus type 16 negative regulatory RNA element interacts with three proteins that act at different posttranscriptional levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Regulation of translation in eukaryotic systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

High guanine and cytosine content increases mRNA levels in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

A human papillomavirus E2 transcriptional activator. The interactions with cellular splicing factors and potential function in pre-mRNA processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

A few nucleotide polymorphisms are sufficient to recruit nuclear factors differentially to the intron 1 of HPV-16 intratypic variants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

SF2/ASF binds the human papillomavirus type 16 late RNA control element and is regulated during differentiation of virus-infected epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

RNA splicing factors regulated by HPV16 during cervical tumour progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Human papillomavirus oncoproteins: pathways to transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Inhibitory cis-element-mediated decay of human papillomavirus type 16 L1-transcript in undifferentiated cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Development and validation of a novel reporter assay for human papillomavirus type 16 late gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Human papillomavirus type 31b infection of human keratinocytes and the onset of early transcription.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

A novel splice donor site at nt 1534 is required for long-term maintenance of HPV31 genomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Alternative splicing of human papillomavirus type-16 E6/E6* early mRNA is coupled to EGF signaling via Erk1/2 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Diagnosing Cervical Cancer and High-Grade Precursors by HPV16 Transcription Patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

7 January 2021

HPV-16 RNA processing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Heterogeneous nuclear ribonucleoprotein C binds exclusively to the functionally important UUUUU-motifs in the human papillomavirus type-1 AU-rich inhibitory element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

AU-rich mRNA instability elements on human papillomavirus type 1 late mRNAs and c-fos mRNAs interact with the same cellular factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Serine/arginine-rich protein 30c activates human papillomavirus type 16 L1 mRNA expression via a bimodal mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Adenovirus E4orf4 induces HPV-16 late L1 mRNA production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3'-splice site on the HPV-16 genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Polypyrimidine tract binding protein induces human papillomavirus type 16 late gene expression by interfering with splicing inhibitory elements at the major late 5' splice site, SD3632

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Early polyadenylation signals of human papillomavirus type 31 negatively regulate capsid gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Translational properties of the human papillomavirus type-6 L1-coding mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

HIV-1 mRNA 3' end processing is distinctively regulated by eIF3f, CDK11, and splice factor 9G8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

The 3' region of human papillomavirus type 16 early mRNAs decrease expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Inhibition of translation by UAUUUAU and UAUUUUUAU motifs of the AU-rich RNA instability element in the HPV-1 late 3' untranslated region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Gene codon composition determines differentiation-dependent expression of a viral capsid gene in keratinocytes in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

The presence of inhibitory RNA elements in the late 3'-untranslated region is a conserved property of human papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Inhibition of HPV-16 L1 expression from L1 cDNAs correlates with the presence of hnRNP A1 binding sites in the L1 coding region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Papillomavirus genome structure, expression, and post-transcriptional regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Optimization of a weak 3' splice site counteracts the function of a bovine papillomavirus type 1 exonic splicing suppressor in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Utilization of the bovine papillomavirus type 1 late-stage-specific nucleotide 3605 3' splice site is modulated by a novel exonic bipartite regulator but not by an intronic purine-rich element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Specific interaction between hnRNP H and HPV16 L1 proteins: implications for late gene auto-regulation enabling rapid viral capsid protein production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Papillomaviruses and cancer: from basic studies to clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

Hierarchy of polyadenylation site usage by bovine papillomavirus in transformed mouse cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

7 January 2021

Analysis of human papillomavirus type 16 late mRNA 3' processing signals in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

7 January 2021

A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

7 January 2021

Human papillomavirus type 18 E1 protein is translated from polycistronic mRNA by a discontinuous scanning mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

7 January 2021

mRNA instability elements in the human papillomavirus type 16 L2 coding region.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

7 January 2021

Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

7 January 2021

The Rev protein of human immunodeficiency virus type 1 counteracts the effect of an AU-rich negative element in the human papillomavirus type 1 late 3' untranslated region.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

7 January 2021

Selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site is regulated through an exonic splicing enhancer and its juxtaposed exonic splicing suppressor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.04.034

7 January 2021

10.1016/J.VIROL.2013.04.034

Identifiers

DOI

1 reference

29 August 2017

1 reference